Cue Biopharma, Inc. CUE
$28.27
-23.70%
at last close
Financials (TTM)
- Revenue
- $37.65 million
- Net Income
- $-164,108,000
- Net Margin
- -435.83%
- Return on Equity
- -7104.24%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 116.51
- Price / Sales
- 7.15
Over the trailing twelve months, Cue Biopharma, Inc. generated revenue of $37.65 million and net income of $-164,108,000, a net margin of -435.83%.
At the last closing price of $28.27, CUE trades at 7.15 times sales, with a market capitalization of $269.15 million.
Key Stats
- Last Close
- $28.27
- Market Cap
- $269.15 million
- 52-Week Range
- $4.97 – $45.50
- Average Volume
- 306K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.